{"id":"W2787959738","doi":"10.1111/dom.13257","title":"Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; Medicine; Internal medicine; Dyslipidemia; PCSK9; Population; Type 2 diabetes; Fenofibrate; Gastroenterology; Endocrinology; Clinical endpoint; Statin; Randomized controlled trial; Cholesterol; Diabetes mellitus; Apolipoprotein B; Lipoprotein; Apolipoprotein A1; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002912581,0.0004267007,0.001700199,0.000240811,0.0003282248,0.0001181642,0.0001664157,0.0002359542,0.00005068962],"category_scores_gemma":[0.0008567505,0.0002556003,0.0001928383,0.000482534,0.0003328059,0.0001475414,0.000111348,0.0004893973,0.00001616662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004270567,"about_ca_system_score_gemma":0.0001898175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001915334,"about_ca_topic_score_gemma":0.00009492653,"domain_scores_codex":[0.9968066,0.0006851265,0.0005204732,0.0006386958,0.0006428524,0.0007063199],"domain_scores_gemma":[0.9981514,0.0004942564,0.0001596958,0.0006019551,0.0002307184,0.0003619909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.363794,0.0009181004,0.1674217,0.0009978625,0.00367306,0.00002412437,0.02832748,0.00001991196,0.003768931,0.001225355,0.001903327,0.4279261],"study_design_scores_gemma":[0.6529739,0.00370902,0.290916,0.000578908,0.0007880515,0.000004106413,0.001143068,0.00003125599,0.02114249,0.000245184,0.02777269,0.0006953487],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863199,0.008571633,0.000008773968,0.0005389124,0.0006886746,0.003483193,0.00002764995,0.00006191745,0.0002993288],"genre_scores_gemma":[0.9934154,0.0008391012,0.0003712585,0.003000514,0.001891612,0.0003253499,0.00003690199,0.00005411835,0.00006577661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4272308,"threshold_uncertainty_score":0.9999896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009826980854002007,"score_gpt":0.2588897558509697,"score_spread":0.2490627749969677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}